A003090 Stock Overview
Engages in the manufacture and sale of pharmaceuticals in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A003090 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Daewoong Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩20,450.00 |
| 52 Week High | ₩28,100.00 |
| 52 Week Low | ₩15,050.00 |
| Beta | 1.23 |
| 1 Month Change | -1.68% |
| 3 Month Change | -21.80% |
| 1 Year Change | 4.66% |
| 3 Year Change | -33.60% |
| 5 Year Change | 60.39% |
| Change since IPO | 840.90% |
Recent News & Updates
These 4 Measures Indicate That Daewoong (KRX:003090) Is Using Debt Extensively
Nov 11
Daewoong Co., Ltd. (KRX:003090) Held Back By Insufficient Growth Even After Shares Climb 26%
Sep 01Recent updates
These 4 Measures Indicate That Daewoong (KRX:003090) Is Using Debt Extensively
Nov 11Daewoong Co., Ltd. (KRX:003090) Held Back By Insufficient Growth Even After Shares Climb 26%
Sep 01Daewoong Co., Ltd.'s (KRX:003090) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 14Is Daewoong (KRX:003090) Using Too Much Debt?
Jul 04Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?
Apr 02With EPS Growth And More, Daewoong (KRX:003090) Is Interesting
Apr 13A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)
Mar 29Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Mar 14Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly
Feb 21The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders
Jan 31
Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?
Dec 04Shareholder Returns
| A003090 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -3.3% | 6.1% | 1.9% |
| 1Y | 4.7% | 5.2% | -7.7% |
Return vs Industry: A003090 matched the KR Pharmaceuticals industry which returned 5.2% over the past year.
Return vs Market: A003090 exceeded the KR Market which returned -7.7% over the past year.
Price Volatility
| A003090 volatility | |
|---|---|
| A003090 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A003090 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003090's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 356 | Yeong-Hwan Yoon | www.daewoongholdings.com |
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd.
Daewoong Co., Ltd. Fundamentals Summary
| A003090 fundamental statistics | |
|---|---|
| Market cap | ₩877.11b |
| Earnings (TTM) | ₩123.36b |
| Revenue (TTM) | ₩1.88t |
6.8x
P/E Ratio0.4x
P/S RatioIs A003090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003090 income statement (TTM) | |
|---|---|
| Revenue | ₩1.88t |
| Cost of Revenue | ₩883.94b |
| Gross Profit | ₩996.14b |
| Other Expenses | ₩872.78b |
| Earnings | ₩123.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.02k |
| Gross Margin | 52.98% |
| Net Profit Margin | 6.56% |
| Debt/Equity Ratio | 41.9% |
How did A003090 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield3%
Payout RatioDoes A003090 pay a reliable dividends?
See A003090 dividend history and benchmarks| Daewoong dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 14 2025 |
| Days until Ex dividend | 8 days |
| Days until Dividend pay date | 116 days |
Does A003090 pay a reliable dividends?
See A003090 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 07:42 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Daewoong Co., Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Hyonseok Kim | CLSA |
| Bora Chung | Daishin Securities Co. Ltd. |